EntreMed ENMD-2076 Phase 2 Data to Be Presented at ASCO Annual Meeting

Thursday, May 19, 2011 General News
Email Print This Page Comment
Font : A-A+

ENMD-2076 Phase 2 Ovarian Cancer Study Accepted for Poster Discussion Session

-

Gynecologic Cancer Track:

Poster Session

Friday, June 3, 2011 – 2:00 p.m. - 6:00 p.m. (CDT) Abstract No.: 5021

Title: A Phase 2 Study of ENMD-2076 in platinum-resistant ovarian cancer

Poster Board: 10, Location: E450a

Discussion Session

Friday, June 3, 2011 – 5:00 p.m. - 6:00 p.m. (CDT)

Location: E354b



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook